PortfoliosLab logoPortfoliosLab logo

Highlights

Market Cap
$245.44M
Enterprise Value
$1.14B
EPS (TTM)
-$14.29
Total Revenue (TTM)
$2.72B
Gross Profit (TTM)
$937.09M
EBITDA (TTM)
$192.32M
Year Range
$1.84 - $9.55
Target Price
$4.00
ROA (TTM)
-45.50%
ROE (TTM)
236.51%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Accendra Health, Inc

Often compared with ACH:
ACH vs. HSIC

Performance

ACH Performance Chart

Accendra Health, Inc (ACH) is up 14.3% since the beginning of the year. At $3 per share, ACH is trading 66.5% below its 52-week high of $10. Investors who bought $1,000 worth of ACH shares 5 years ago would now be looking at an investment worth $76.


Loading charts...

S&P 500 Index

Returns By Period

Accendra Health, Inc (ACH) has returned 14.29% so far this year and -56.40% over the past 12 months. Over the last ten years, ACH has returned -20.83% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Accendra Health, Inc

1D
-0.93%
1M
13.07%
YTD
14.29%
6M
19.40%
1Y
-56.40%
3Y*
-44.42%
5Y*
-40.21%
10Y*
-20.83%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ACH Monthly Returns History

Based on dividend-adjusted daily data since Dec 16, 1988, ACH's average daily return is +0.05%, while the average monthly return is +1.04%. At this rate, an investment would double in approximately 5.6 years.

Historically, 52% of months were positive and 48% were negative. The best month was Jul 2020 with a return of +111.0%, while the worst month was Oct 2018 at -52.2%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 6 months.

On a daily basis, ACH closed higher 47% of trading days. The best single day was Jul 21, 2020 with a return of +81.4%, while the worst single day was Oct 31, 2018 at -44.4%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-21.07%9.50%-5.79%62.72%-23.45%12.68%14.29%
20258.95%-32.72%-5.74%-21.82%-6.52%37.88%-23.85%-29.29%-2.04%-17.29%-31.49%2.94%-78.58%
20242.28%23.44%13.89%-10.72%-29.55%-22.55%21.63%-5.36%0.97%-18.99%5.98%-2.97%-32.17%
20231.08%-22.34%-5.09%6.80%30.69%-6.25%1.05%-12.16%-4.38%-11.32%38.73%-3.07%-1.33%
2022-3.24%4.89%-0.29%-19.38%-1.72%-9.83%12.59%-16.66%-18.33%-29.46%21.24%-5.24%-55.10%
20217.50%16.95%10.53%-3.99%23.88%-5.32%9.26%-19.39%-16.06%14.67%11.48%8.76%60.85%

Benchmark Metrics

Accendra Health, Inc has an annualized alpha of 6.35%, beta of 0.72, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since December 16, 1988.

  • This stock participated in 72.03% of S&P 500 Index downside but only 47.38% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
6.35%
Beta
0.72
0.07
Upside Capture
47.38%
Downside Capture
72.03%

Return for Risk

Risk / Return Rank

ACH ranks 17 for risk / return — in the bottom 17% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


ACH Risk / Return Rank: 1717
Overall Rank
ACH Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
ACH Sortino Ratio Rank: 1717
Sortino Ratio Rank
ACH Omega Ratio Rank: 1717
Omega Ratio Rank
ACH Calmar Ratio Rank: 1616
Calmar Ratio Rank
ACH Martin Ratio Rank: 2323
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Accendra Health, Inc (ACH) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ACHBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.68

Sortino ratioReturn per unit of downside risk

-3.40

Omega ratioGain probability vs. loss probability

0.91

1.37

-0.45

Calmar ratioReturn relative to maximum drawdown

-0.71

2.78

-3.49

Martin ratioReturn relative to average drawdown

-0.92

12.44

-13.36

Dividends

Dividend History

Accendra Health, Inc provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%2.00%4.00%6.00%8.00%10.00%12.00%14.00%$0.00$0.20$0.40$0.60$0.80$1.0020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$0.00$0.00$0.00$0.00$0.00$0.01$0.01$0.01$0.86$1.03$1.02$1.01

Dividend yield

0.00%0.00%0.00%0.00%0.00%0.02%0.04%0.19%13.51%5.46%2.89%2.81%

Monthly Dividends

The table displays the monthly dividend distributions for Accendra Health, Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2025$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.01

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Accendra Health, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Accendra Health, Inc was 96.08%, occurring on Jan 6, 2026. The portfolio has not yet recovered.

The current Accendra Health, Inc drawdown is 93.43%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-96.08%Jan 2026
4y 7mo
5y 15dJun 2021 - now
2019 bear market2019
-93.26%Jul 2019
3y 3mo1y 7mo
4y 10moApr 2016 - Mar 2021
1999 bear market1999
-58.84%Nov 1999
1y 7mo1y 5mo
3y 1moMar 1998 - Apr 2001
1996 bear market1996
-46.82%Sep 1996
2y 6mo1y 4mo
3y 11moMar 1994 - Feb 1998
Financial crisis2007–2009
-37.16%Mar 2009
7mo 24d1y 28d
1y 8moJul 2008 - Apr 2010

Drawdown Indicators


ACHBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-96.08%

-56.78%

-39.30%

Max Drawdown (1Y)

Largest decline over 1 year

-79.72%

-9.10%

-70.62%

Max Drawdown (3Y)

Largest decline over 3 years

-93.17%

-18.90%

-74.27%

Max Drawdown (5Y)

Largest decline over 5 years

-96.00%

-25.43%

-70.57%

Max Drawdown (10Y)

Largest decline over 10 years

-96.08%

-33.92%

-62.16%

Current Drawdown

Current decline from peak

-93.43%

-1.80%

-91.63%

Average Drawdown

Average peak-to-trough decline

-25.52%

-10.71%

-14.81%

Ulcer Index

Depth and duration of drawdowns from previous peaks

61.01%

2.03%

+58.98%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Accendra Health, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Accendra Health, Inc is priced in the market compared to other companies in the Medical Distribution industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ACH relative to other companies in the Medical Distribution industry. Currently, ACH has a P/S ratio of 0.1. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with ACH

Add Accendra Health, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with ACH